Tencent revenues increased by 13% to RMB142.4 billion for the third quarter of 2021 on a year-on-year basis.<blockquote>2021年第三季度腾讯控股收入同比增长13%至人民币1,424亿元。</blockquote>
Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis<blockquote>辉瑞公司的3期Jade Dare试验比较了Abrocitinib和Dupilumab治疗中度至重度特应性皮炎的疗效,取得了积极的顶线结果</blockquote>